ArticlesPricing

Products

See All Solutions →
By ProductEMARKETER PRO+Analyst Access Program
By Use CaseDetermine Market SizingDevelop StrategiesAllocate BudgetBenchmark PerformanceWin New BusinessDevelop Go-to-Market Strategy
Advertising & Sponsorship
Boost your brand and generate demand with media programs.
Learn More →

Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More →
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More →
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More →

Topics

See All Topics →
Advertising & MarketingSocial MediaContent MarketingEmail MarketingVideoBrowse All →
Ecommerce & RetailEcommerce SalesMcommerceRetail SalesSocial CommerceBrowse All →
Financial ServicesBankingPaymentsFintechWealth ManagementBrowse All →
GeographiesAsia-PacificCentral & Eastern EuropeLatin AmericaMiddle East & AfricaNorth AmericaWestern Europe
HealthValue-Based CareDigital TherapeuticsTelehealthOnline PharmacyBrowse All →
TechnologyConnected Devices5GArtificial Intelligence (AI)Browse All →
More IndustriesReal EstateCustomer ExperienceB2BTravelSmall Business (SMB)Browse All →

Latest Articles

Explore our Research →

Tariffs put over $2 trillion in trade with Mexico, Canada, and China at risk

Article |
 Mar 6, 2025

4 IRL retail trends and what they mean for brands

Article |
 Mar 6, 2025

Apple's new social app reveals event opportunities for marketers

Article |
 Mar 6, 2025

Reddit sees growth as users seek relatable content

Article |
 Mar 6, 2025

Creatives struggle with inconsistent metrics when measuring ad performance

Article |
 Mar 5, 2025

GenAI-influenced reviews, research, and recommendations craft a new era for shoppers

Article |
 Mar 5, 2025

Brands find creator economy use cases for AI

Article |
 Mar 5, 2025

Target faces 40-day boycott as it deals with tariffs, economic blackout

Article |
 Mar 5, 2025

Microsoft Copilot launches AI-powered ad features to vie for ad dollars in the chatbot space

Article |
 Mar 5, 2025

Millennials lead in wearable tech as Gen Z adoption grows

Article |
 Mar 5, 2025
Browse All →

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More →
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More →
Our People
Take a look into our corporate culture and view our open roles.
Join the Team →
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More →
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More →
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us →
EMARKETER

Health Trends to Watch in 2025

Weight Loss Drugs and Shifting Buying Behaviors Push More Companies Into D2C Healthcare

Report by Dane Finley, Rajiv Leventhal  |  Dec 13, 2024

Top Trends to Watch in 2025

Need-to-Know Trends Across 12 Industries and 6 Regions

more
See All
Download
Report
Share
Table of Contents
D2C will become a viable distribution channel for healthcare and pharma companies
The clash between Big Pharma and some D2C weight loss drug sellers will worsen
The cost of healthcare will drive more consumers to become price-conscious
Sources
Media Gallery
About This Report
Healthcare and pharma companies are embracing D2C business models to get their medications, treatments, and services to more consumers without industry middlemen restricting access. Concurrently, patients are becoming more price-conscious healthcare shoppers, propelling more D2C activity next year.
Topics
Health
Digital Health
Healthcare Providers
United States
Table of Contents
D2C will become a viable distribution channel for healthcare and pharma companies
The clash between Big Pharma and some D2C weight loss drug sellers will worsen
The cost of healthcare will drive more consumers to become price-conscious
Sources
Media Gallery

Healthcare and pharma companies are selling more medical services and treatments directly to consumers online. Yet D2C’s rise in this sector is creating conflict between incumbents and upstarts, particularly around trendy weight loss drugs. Patients’ willingness to comparison shop for healthcare suggests escalating D2C activity in 2025.

Here’s what’s in the full report

1file

Exportable files for easy reading, analysis and sharing.

3charts

Reliable data in simple displays for presentations and quick decision making.

Table of Contents

  1. D2C will become a viable distribution channel for healthcare and pharma companies
  2. The clash between Big Pharma and some D2C weight loss drug sellers will worsen
  1. The cost of healthcare will drive more consumers to become price-conscious
  2. Sources
  1. Media Gallery

Charts in This Report

Subscriptions for Primary Care or Prescriptions Are More Popular Among Younger Generations (% of US consumers, by generation, Dec 2023)Competition Over Customers Is the Most Anticipated GLP-1 Market Development
Gen Z and Millennials Are Most Likely to Compare Prices for Medications and Medical Services (% of US consumers, by generation, Dec 2023)

authors

Dane Finley, Rajiv Leventhal

Contributors

Vladimir de Leon
Chart Editor
Jennifer Pearson
VP, Research
Heather Sprung
Senior Editor
Emman Velasco
Chart Editor
Paul Verna
VP, Content
Ali Young
Senior Copy Editor
Already have a subscription?Sign In

Access All Charts and Data

Gain access to reliable data presented in clear and intelligible displays for quick understanding and decision making on the most important topics related to your industry

Become a Client